Artixio

Regulatory Intelligence and Strategy

Maximize Your Portfolio Potential in Global Markets while Ensuring Compliance using Tech-Assisted, AI-Enabled Regulatory Intelligence Solutions and Services

Our Approach to Regulatory Intelligence

Global Regulations are complex, often ambiguous. Our Regulatory Intelligence services help you access actionable insights based global regulations coupled with hands-on experience of our teams from successful registrations in past. With Artixio, command your global regulatory intelligence and policy enabling streamlined global market access regulatory strategy for successful product launch and ongoing compliance maintenance. Our team works closely with you helping you support your cross-functional team through the Regulatory Intelligence process right from information gathering, synthesis to formulating actionable insights and Regulatory Strategy.

Regulatory Information Gathering → Synthesis → Regulatory Intelligence & Strategy → Strategy Deployment

Extensive Intelligence Inputs for Actional Insights

Actionable Insights End to End Product Lifecycle Management Strategy

Expert Analysis for Multi-Dimensional Intelligence

Comprehensive Coverage of Intelligence Sources:

Regulatory Functions Supported by Regulatory Intelligence:

Go beyond Regulatory Intelligence Database, Artixio offers RI-Driven Strategy Development, Gap Assessment and Dossier Preparation tool to put insights into action using Dvarka.

Artixio’s Regulatory Intelligence Difference:

FAQS About Regulatory Intelligence

What are the Key Components of Regulatory Intelligence and Strategy?

Regulatory Intelligence is proactive assessment of global regulations to formulate and deploy a global product development, product registration and post approval compliance maintenance strategy. It also includes continuous monitoring of changes in regulations from Health Authorities around the world to assess the impact on business from the regulatory standpoint. Right from requirement for additional studies, changes in labelling and packaging requirements, additional testing for dangerous ingredients, product safety assurance, pharmacovigilance and other areas that can hinder the product development, registration, supply chain or business continuity.

Regulatory Intelligence includes three stages at high-level, i.e., sourcing the information, synthesis of the data, creating intelligence to formulate the strategy and deployment of the strategy.

Health Authority website, updates are main source of data as they provide standard guidelines, notifications, news directly from the Ministries, Government and Regulatory Bodies. These sources are available online for global audience. Some countries may publish the information in local language that may need certified translation. Often some websites are delayed in relaying the complete information despite implementation of changes.

In addition, regional Trade associations, Industry Trade Events offer primary source of intelligence for potential and upcoming changes in regulations and/or insights on navigating current regulations. Often, in certain countries, these associations and events are quite useful resources as the information on HA website may not be immensely helpful to fully understand the regulations and changes.

Regional regulatory experts are a useful source of primary regulatory intelligence based on their experience and insights from their regional industry and HA network.

Our global Regulatory Intelligence and Strategy support services leverage Artixio’s following capabilities:

Regional Regulatory Experts based in 70+ countries with proven experience, local professional and HA network and trade associations memberships.

Continuous monitoring of Global HA website and other relevant sources of Regulatory updates for real-time regulatory tracking

Centralized Regulatory Intelligence team of experts to track, assess, evaluate, and prepare intelligence summaries

Experience from successfully completed projects and responses to thousands of regulatory queries in global markets

Automated, AI-enabled technology platform for storage and deployment of regulatory intelligence insights for Real-Time Application across regulatory functions

Some of the challenges faced by Companies include:

Lack of clarity on global regulations and comparison to regulated markets such as USA and Europe

Access to regulatory guidelines and updates from global HAs

Lack of access to regional insights and primary intelligence from local experts, authorities, and industry professionals

Lack of insights from practical experience of successful submissions or lifecycle maintenance

Lack of comprehensive, efficient, cost-effective regulatory intelligence platform covering major markets globally

We are concurrent with existing, new and changes in regulations by continuously monitoring any Health Authority updates, notifications, and announcements for announced or upcoming changes.

Our regional Regulatory Experts have decades of experience working with local HAs on diverse, complex products and have helped hundreds of products with successful navigation of regulations.

Our team members are part of regional industry network, trade associations and HA officials to proactively seek insights on potential new regulations and changes.

Using different data sources, we synthesize the insights in structured format for our partners and clients.

 

Still Have Questions ?

Get expert answers tailored to your needs.

Specialized Regulatory Intelligence Services Across Multiple Industries

Pharmaceuticals

MedTech

Cosmetics

Nutrition

Biologics

Veterinary

Expert Regulatory Services To Streamline Compliance

Regulatory Intelligence & Strategy
Medical & Technical Writing
Publishing & Submission
Product Registration
Investigation New Drug Application (IND)
New Drug Application (NDA)
Post Approval Lifecycle Maintenance
Artwork and Label Review
Ad Promo Review

Regulatory Services Across Multiple Countries

India

Singapore

Mexico

Brazil

Vietnam

Malaysia

Argentina

Colombia

Taiwan

China

European

Thailand

Indonesia

Philippines

USA

Japan

Qatar

South Korea

Insights from Artixio - Tips & Articles

Pharma Manufacturing Booms in Hidalgo, Mexico

Pharma Manufacturing Booms in

Hildalgo had good pharmaceutical infrastructure and supply chain capabilities, but with no foreign investment...

May 2, 2025
UK Releases Amendment & Guidance on Regulations in 2024 for Medical Devices (Post-market Surveillance Requirements)

UK Releases Amendment &

In January 2025, MHRA UK released guidance on implementation of amendments to Medical Devices...

April 23, 2025
Artixio Announces Grant for Early Stage Medtech Innovators as Part of MedTech InnovateIO Initiative

Artixio Announces Grant for

HYDERABAD, India - March 27, 2024 - Artixio, a leading compliance and commercial consulting...

April 16, 2025